Zydus Cadila gets USFDA nod for high blood pressure, heart failure treatment drug
Zydus Cadila has received final approval from the US health regulator to market Spironolactone tablets, used to treat high blood pressure and heart20-07-2018
20-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Spironolactone Tablets USP20-07-2018
Zydus Cadila gets USFDA nod for arthritis drug
Zydus Cadila has received final approval from the US health regulator for Piroxicam capsules, used for the treatment of osteoarthritis and rheumatoid19-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Piroxicam Capsules USP19-07-2018
Zydus Cadila gets USFDA nod to market 4 generic products
Pharma firm Zydus Cadila today said it has received final approvals from the US health regulator to market four generic products in America. The comp18-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives four consecutive ANDA approvals from the USFDA18-07-2018
Cadila Healthcare jumps nearly 3%
Shares of Cadila Healthcare jumped nearly 3 per cent to Rs 360 as Zydus Cadila has received final approval from the US health regulator to market Clin17-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Clindamycin Phosphate Topical Solution USP17-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Hospira JV receives EIR Report for its Manufacturing Facility at Ahmedabad12-07-2018